Atlas Trials

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Clinical trial NCT01824836 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01824836
Sponsor
ECOG-ACRIN Cancer Research Group
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor-positive Breast CancerMusculoskeletal ComplicationsProgesterone Receptor-positive Breast CancerRecurrent Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Start date
2013-06-11
Primary completion
2022-06-09
Enrollment
1046

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.